同时使用贝达喹啉-德拉马尼的耐药结核病患者12个月的持续治疗成功。

{"title":"同时使用贝达喹啉-德拉马尼的耐药结核病患者12个月的持续治疗成功。","authors":"V Chavan, A Silsarma, R Mahajan, S Khan, P Singh, A Iyer, A Dalal, H Spencer, P Isaakidis","doi":"10.5588/ijtldopen.24.0600","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":519984,"journal":{"name":"IJTLD open","volume":"2 2","pages":"107-109"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11827666/pdf/","citationCount":"0","resultStr":"{\"title\":\"Sustained treatment success at 12 months for drug-resistant TB patients on concomitant bedaquiline-delamanid.\",\"authors\":\"V Chavan, A Silsarma, R Mahajan, S Khan, P Singh, A Iyer, A Dalal, H Spencer, P Isaakidis\",\"doi\":\"10.5588/ijtldopen.24.0600\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":519984,\"journal\":{\"name\":\"IJTLD open\",\"volume\":\"2 2\",\"pages\":\"107-109\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11827666/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IJTLD open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5588/ijtldopen.24.0600\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJTLD open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/ijtldopen.24.0600","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}